Regulatory
DEC: dequalinium chloride risks in the Granzofen risk management plan summary
When using dequalinium chloride vaginal tablets, consider the risk of vaginal epithelial ulcers and potential allergic reactions. Safety data are absent for patients over 55 years of age and for repeated use.
#dequalinium chloride dec.gov.ua